Golimumab Subcutaneous and Octreotide Acetate
Determining the interaction of Golimumab Subcutaneous and Octreotide Acetate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Octreotide injection
- Golimumab Subcutaneous-Octreotide Injection, Intramuscular
- Golimumab Subcutaneous-Octreotide Long-Acting Injection
- Golimumab Subcutaneous-Ocu-Carpine
- Golimumab Subcutaneous-Ocu-Chlor
- Golimumab Subcutaneous-Ocu-Dex
- Octreotide Acetate-GoLYTELY
- Octreotide Acetate-Gonadorelin
- Octreotide Acetate-Gonadorelin Intravenous, Injection
- Octreotide Acetate-Gonadotropin, Chorionic
- Octreotide Acetate-Gonal-F
- Octreotide Acetate-Gonal-f RFF